These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22162987)

  • 1. RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies.
    Herder C; Peeters W; Illig T; Baumert J; de Kleijn DP; Moll FL; Poschen U; Klopp N; Müller-Nurasyid M; Roden M; Preuss M; ; Karakas M; Meisinger C; Thorand B; Pasterkamp G; Koenig W; Assimes TL; Deloukas P; Erdmann J; Holm H; Kathiresan S; König IR; McPherson R; Reilly MP; Roberts R; Samani NJ; Schunkert H; Stewart AF
    PLoS One; 2011; 6(12):e25734. PubMed ID: 22162987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Herder C; Illig T; Baumert J; Müller M; Klopp N; Khuseyinova N; Meisinger C; Poschen U; Martin S; Koenig W; Thorand B
    Eur J Endocrinol; 2008 May; 158(5):R1-5. PubMed ID: 18426815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events.
    Herder C; Peeters W; Zierer A; de Kleijn DP; Moll FL; Karakas M; Roden M; Meisinger C; Thorand B; Pasterkamp G; Koenig W
    Eur J Clin Invest; 2012 Mar; 42(3):329-37. PubMed ID: 21950567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemokine CCL5/RANTES and metalloproteinase-9 as inflammatory modulators in symptomatic internal carotid artery stenosis.
    Badacz R; Podolec J; Przewlocki T; Siedlinski M; Jozefczuk E; Oleksy H; Baran J; Pieniazek P; Zmudka K; Kablak-Ziembicka A
    J Physiol Pharmacol; 2019 Aug; 70(4):. PubMed ID: 31642817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of RANTES levels as the indicators of plaque vulnerability in rabbit models of atherosclerosis.
    Lv YB; Jing J; Li JM; Zhong JP; Fang L; Yang B
    Pathol Res Pract; 2014 Dec; 210(12):1031-7. PubMed ID: 25155378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study.
    Herder C; Baumert J; Zierer A; Roden M; Meisinger C; Karakas M; Chambless L; Rathmann W; Peters A; Koenig W; Thorand B
    PLoS One; 2011; 6(6):e19852. PubMed ID: 21674000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events.
    Rattik S; Wigren M; Björkbacka H; Fredrikson GN; Hedblad B; Siegbahn A; Bengtsson E; Schiopu A; Edsfeldt A; Dunér P; Grufman H; Gonçalves I; Nilsson J
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):222-8. PubMed ID: 25359857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.
    Virani SS; Nambi V; Hoogeveen R; Wasserman BA; Coresh J; Gonzalez F; Chambless LE; Mosley TH; Boerwinkle E; Ballantyne CM
    Eur Heart J; 2011 Feb; 32(4):459-68. PubMed ID: 20943669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine RANTES is increased at early stages of coronary artery disease.
    Podolec J; Kopec G; Niewiara L; Komar M; Guzik B; Bartus K; Tomkiewicz-Pajak L; Guzik TJ; Plazak W; Zmudka K
    J Physiol Pharmacol; 2016 Apr; 67(2):321-8. PubMed ID: 27226191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.
    de Jager SC; Bongaerts BW; Weber M; Kraaijeveld AO; Rousch M; Dimmeler S; van Dieijen-Visser MP; Cleutjens KB; Nelemans PJ; van Berkel TJ; Biessen EA
    PLoS One; 2012; 7(9):e45804. PubMed ID: 23029252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Herder C; Illig T; Baumert J; Müller M; Klopp N; Khuseyinova N; Meisinger C; Martin S; Thorand B; Koenig W
    Atherosclerosis; 2008 Oct; 200(2):380-8. PubMed ID: 18242614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
    Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
    J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.
    Jang Y; Chae JS; Hyun YJ; Koh SJ; Kim JY; Ko MJ; Rim SJ; Shin HJ; Ordovas JM; Lee JH
    Clin Sci (Lond); 2007 Oct; 113(8):349-56. PubMed ID: 17504241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent roles of monocyte chemoattractant protein-1, regulated on activation, normal T-cell expressed and secreted and fractalkine in the vulnerability of coronary atherosclerotic plaques.
    Li J; Guo Y; Luan X; Qi T; Li D; Chen Y; Ji X; Zhang Y; Chen W
    Circ J; 2012; 76(9):2167-73. PubMed ID: 22664781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum level of beta-chemokine RANTES in patients with coronary artery disease].
    Kobusiak-Prokopowicz M; Jołda-Mydłowska B; Mazur G; Kuliczkowski W
    Pol Arch Med Wewn; 2003 Nov; 110(5):1289-97. PubMed ID: 16736999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
    Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
    Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study.
    Canouï-Poitrine F; Luc G; Mallat Z; Machez E; Bingham A; Ferrieres J; Ruidavets JB; Montaye M; Yarnell J; Haas B; Arveiler D; Morange P; Kee F; Evans A; Amouyel P; Ducimetiere P; Empana JP;
    Neurology; 2011 Sep; 77(12):1165-73. PubMed ID: 21849651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X chromosome inactivation skewing is common in advanced carotid atherosclerotic lesions in females and predicts secondary peripheral artery events.
    Buono MF; Benavente ED; Daniels M; Mol BM; Mekke JM; de Borst GJ; de Kleijn DPV; van der Laan SW; Pasterkamp G; Onland-Moret C; Mokry M; den Ruijter HM
    Biol Sex Differ; 2023 Jul; 14(1):43. PubMed ID: 37408072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome.
    Nomura S; Uehata S; Saito S; Osumi K; Ozeki Y; Kimura Y
    Thromb Haemost; 2003 Mar; 89(3):506-12. PubMed ID: 12624635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL5/RANTES gene polymorphisms in Slavonic patients with myocardial infarction.
    Tereshchenko IP; Petrkova J; Voevoda MI; Taborsky M; Navratilova Z; Romaschenko AG; Maksimov VN; Mrazek F; Petrek M
    Mediators Inflamm; 2011; 2011():525691. PubMed ID: 21547257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.